Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Jiang, Qian  [Clear All Filters]
Journal Article
Wang, J., Huang, X.Jun, Jiang, B., Jiang, Q., Lu, X.Jing, Xu, L.Ping, Liu, D.Hong, Chen, H., Bao, L., Lu, J., et al. (2013). [Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia].Beijing Da Xue Xue Bao45, 938-44.
Li, X., Jiang, Q., Wang, T., Liu, J., and Chen, D. (2016). Comparison of the Antioxidant Effects of Quercitrin and Isoquercitrin: Understanding the Role of the 6″-OH Group.Molecules21.
Zhang, J.-M., Xu, Y., Gale, R.P., Wu, L.-X., Zhang, J., Feng, Y.-H., Qin, Y.-Z., Jiang, H., Jiang, Q., Jiang, B., et al. (2020). DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia.Br J Haematol.
Zhao, X.-Y., Jiang, Q., Jiang, H., Hu, L.-J., Zhao, T., Yu, X.-X., and Huang, X.-J. (2020). Expanded clinical-grade membrane-bound IL-21/4-1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo.Eur J Immunol.
Zhao, H., Tang, H., Xiao, Q., He, M., Zhao, L., Fu, Y., Wu, H., Yu, Z., Jiang, Q., Yan, Y., et al. (2016). The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24‑ phenotype.Mol Med Rep.
He, M., Fu, Y., Yan, Y., Xiao, Q., Wu, H., Yao, W., Zhao, H., Zhao, L., Jiang, Q., Yu, Z., et al. (2015). The Hedgehog signaling pathway mediates drug response of MCF-7 mammosphere cells and breast cancer patients.Clin Sci (Lond).
Jiang, Q., and Gale, R.Peter (2016). Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China.J Cancer Res Clin Oncol.
Qin, Y.-Z., Jiang, Q., Jiang, H., Lai, Y.-Y., Shi, H.-X., Chen, W.-M., Yu, L., and Huang, X.-J. (2018). Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre.Br J Haematol.
Wang, Y.-Z., Hao, L., Chang, Y., Jiang, Q., Jiang, H., Zhang, L.-P., He, L.-L., Yuan, X.-Y., Qin, Y.-Z., Huang, X.-J., et al. (2018). A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype.Leuk Res72, 12-19.
Jiang, Q., Liu, Z.-C., Zhang, S.-X., and Gale, R.Peter (2016). Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia.J Cancer Res Clin Oncol.